
Cancer Australia’s Corporate Plan 2024-25
Cancer Australia develops a Corporate Plan annually, that covers a four-year period, in accordance with the mandatory requirements in the Public Governance, Performance and Accountability Act 2013 (PGPA Act) and the Public Governance, Performance and Accountability Rule 2014 (PGPA Rule).
The report sets out the objectives and key activities Cancer Australia intends to pursue to achieve its purpose. As required under section 16E of the PGPA Rule, the Corporate Plan has been developed to include:
- an introduction
- the purpose of the entity
- key activities the entity will undertake
- the operating context of the entity, including the environment in which the entity operates, its cooperative relationships, key capabilities, and risk oversight and management systems
- the planned performance of the entity, including details of the methodology, data and information that it will use to measure and assess its performance
Cancer Australia Corporate Plans can also be found at transparency.gov.au.
Previous Corporate Plans:
- Cancer Australia Corporate Plan 2024-2025
- Cancer Australia Corporate Plan 2023-2024
- Cancer Australia Corporate Plan 2022-2023
- Cancer Australia Corporate Plan 2020-2021
- Cancer Australia Corporate Plan 2019-20
- Cancer Australia Corporate Plan 2018-19
- Cancer Australia Corporate Plan 2017-18
- Cancer Australia Corporate Plan 2016-17
- Cancer Australia Corporate Plan 2015-16
Accessibility
If you experience difficulties downloading, accessing or ordering any Cancer Australia resource, please call 02 9357 9400 or email us at enquiries@canceraustralia.gov.au.